MedTrace Logo

Indirect Pulp Treatment in Primary Molars

NCT03770871 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2019-08-30

No results posted yet for this study

Summary

This study was conducted to evaluate the clinical and the radiographic success of Dycal and Vitrebond as indirect pulp treatment materials in primary molars.

Conditions

  • Dental Caries

Interventions

DRUG

Indirect pulp treatment using Dycal (TM)

Partial caries removal and protection of the dental pulp with biocompatible material

DRUG

Indirect pulp treatment using Vitrebond (TM )

Partial caries removal and protection of the dental pulp with biocompatible material

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Shereen E Taha, Professor · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
8 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2017-08-31
Completion
2018-07-31
FDA Drug
Yes

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03770871 on ClinicalTrials.gov